Evidence map›Paper›PMID 41191093›Full record

ArticleMikrochimica acta2025

CRISPR-assisted MoS

Yinuo Sun, Han Han, Rongtao Zhao, Xiaoxian Liu, Zhenzhen Liu, Jing Liang, Bingwei Wang, Baohua Zhao, Yuanfeng Pang, Rui Xiao

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yinuo SunState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, 10071, China.
Han HanState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, 10071, China.
Rongtao ZhaoChinese PLA Center for Disease Control and Prevention, Beijing, 10071, China.
Xiaoxian LiuState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, 10071, China.
Zhenzhen LiuState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, 10071, China.
Jing LiangState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, 10071, China.
Bingwei WangState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, 10071, China.
Baohua ZhaoCollege of Life Science, Hebei Normal University, Shijiazhuang, 050024, People's Republic of China. zhaobaohua@hebtu.edu.cn.
Yuanfeng PangCapital Medical University, No.10 Xitoutiao, You An Men, Beijing, 100069, China. yuanfengpang@ccmu.edu.cn.
Rui XiaoState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, 10071, China. ruixiao203@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) assembled lateral flow assay (LFA) have been developed for rapid virus diagnosis, however, the single-mode visual half-quantitative characteristics limit their applications in accurate quantitative diagnosis. Herein, a CRISPR assisted MoS

Indexed as

Clustered Regularly Interspaced Short Palindromic RepeatsCOVID-19DisulfidesMolybdenumQuantum DotsSARS-CoV-2ColorimetryCOVID-19 TestingCRISPR-Cas SystemsHumansLimit of DetectionNanostructuresDisulfidesMolybdenummolybdenum disulfide2; CRISPRCas13; RTCoVMode LFA; SARSMoS2@TQD;RAA

Identifiers

PMID41191093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.